The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant dynamic marker-adjusted personalized therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel + carboplatin + trastuzumab + pertuzumab in HER2+ early breast cancer: WSG-ADAPT-HER2-IV.
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - AstraZeneca; Daiichi-Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; Viatris; Zuelligpharma
Consulting or Advisory Role - Gilead Sciences; Roche/Genentech; Seagen; West German Study Group (I)
Speakers' Bureau - EPG Communication; Medscape; Springer Healthcare
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Roche/Genentech (Inst)
 
Michael Braun
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Gilead Sciences; Novartis; Pfizer
Speakers' Bureau - Exact Sciences; Novartis
 
Oleg Gluz
Honoraria - AstraZeneca; Celgene; Exact Sciences; Gilead Sciences; Lilly; MSD; NanoString Technologies; Novartis; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Exact Sciences; Genomic Health; Lilly; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
 
Peter Schmid
Employment - Roche (I)
Honoraria - AstraZeneca; Bayer; Bayer; Boehringer Ingelheim; Celgene; Celgene; Eisai; Genentech (Inst); Gilead Sciences Hong Kong; Merck; Novartis; Oncogenex (Inst); Oncogenex (Inst); Pfizer; Puma Biotechnology; Roche; Sanofi; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation; Novartis (Inst); Oncogenex (Inst); Roche (Inst)
Travel, Accommodations, Expenses - ESMO; SABS
 
Monika Karla Graeser
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Andreas D. Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Daiichi Sankyo; Genomic Health; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Oliver Hoffmann
No Relationships to Disclose
 
Athina Kostara
No Relationships to Disclose
 
Silke Polata
No Relationships to Disclose
 
Lea Louise Volmer
No Relationships to Disclose
 
Raquel von Schumann
No Relationships to Disclose
 
Sarah Wetzig
No Relationships to Disclose
 
Stefanie Wiebe
No Relationships to Disclose
 
Matthias R. Zaiss
No Relationships to Disclose
 
Lotta Ada Fischer
Honoraria - Mammotome; Mammotome
Travel, Accommodations, Expenses - Mammotome
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Iris Scheffen
No Relationships to Disclose
 
Matthias Christgen
No Relationships to Disclose
 
Hans Heinrich Kreipe
No Relationships to Disclose
 
Ulrike Nitz
Honoraria - Agendia; Amgen; AstraZeneca; Celgene; Exact Sciences; NanoString Technologies; Novartis Biociencias; Pfizer; Roche/Genentech; Seagen
Consulting or Advisory Role - Roche
Research Funding - Amgen; Celgene; Exact Sciences; NanoString Technologies; Pfizer; Roche
Expert Testimony - Exact Sciences
Travel, Accommodations, Expenses - Exact Sciences; Pfizer; Roche
 
Sherko Kuemmel
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Hologic; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; PINK; Roche/Genentech; Seagen; SOMATEX; Sonoscape; Stryker
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Roche
(OPTIONAL) Uncompensated Relationships - West German Study Group